• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医疗设备:美国医疗设备监管

Medical devices: US medical device regulation.

作者信息

Jarow Jonathan P, Baxley John H

机构信息

US Food and Drug Administration, Silver Spring, MD.

US Food and Drug Administration, Silver Spring, MD.

出版信息

Urol Oncol. 2015 Mar;33(3):128-32. doi: 10.1016/j.urolonc.2014.10.004. Epub 2014 Nov 6.

DOI:10.1016/j.urolonc.2014.10.004
PMID:25458071
Abstract

Medical devices are regulated by the US Food and Drug Administration (FDA) within the Center for Devices and Radiological Health. Center for Devices and Radiological Health is responsible for protecting and promoting the public health by ensuring the safety, effectiveness, and quality of medical devices, ensuring the safety of radiation-emitting products, fostering innovation, and providing the public with accurate, science-based information about the products we oversee, throughout the total product life cycle. The FDA was granted the authority to regulate the manufacturing and marketing of medical devices in 1976. It does not regulate the practice of medicine. Devices are classified based on complexity and level of risk, and "pre-1976" devices were allowed to remain on the market after being classified without FDA review. Post-1976 devices of lower complexity and risk that are substantially equivalent to a marketed "predicate" device may be cleared through the 510(k) premarket notification process. Clinical data are typically not needed for 510(k) clearance. In contrast, higher-risk devices typically require premarket approval. Premarket approval applications must contain data demonstrating reasonable assurance of safety and efficacy, and this information typically includes clinical data. For novel devices that are not high risk, the de novo process allows FDA to simultaneously review and classify new devices. Devices that are not legally marketed are permitted to be used for clinical investigation purposes in the United States under the Investigational Device Exemptions regulation.

摘要

美国食品药品监督管理局(FDA)下属的器械与放射健康中心负责监管医疗器械。器械与放射健康中心负责通过确保医疗器械的安全性、有效性和质量,确保辐射发射产品的安全性,促进创新,并在整个产品生命周期内向公众提供有关我们所监管产品的准确、基于科学的信息,来保护和促进公众健康。FDA于1976年被授予监管医疗器械制造和销售的权力。它不监管医疗实践。器械根据复杂性和风险水平进行分类,“1976年前”的器械在分类后无需FDA审查即可继续留在市场上。1976年后复杂性和风险较低且与已上市的“同类参照”器械实质等同的器械,可通过510(k)上市前通知程序获得批准。510(k)批准通常不需要临床数据。相比之下,高风险器械通常需要上市前批准。上市前批准申请必须包含证明安全性和有效性合理保证的数据,这些信息通常包括临床数据。对于非高风险的新型器械,“从头开始”程序允许FDA同时对新器械进行审查和分类。根据研究性器械豁免规定,在美国,未合法上市的器械可用于临床研究目的。

相似文献

1
Medical devices: US medical device regulation.医疗设备:美国医疗设备监管
Urol Oncol. 2015 Mar;33(3):128-32. doi: 10.1016/j.urolonc.2014.10.004. Epub 2014 Nov 6.
2
An overview of Food and Drug Administration regulation of drugs, biologics, and devices to be used for management of periodontal diseases.美国食品药品监督管理局对用于牙周疾病管理的药物、生物制品和器械的监管概述。
Ann Periodontol. 1997 Mar;2(1):11-7. doi: 10.1902/annals.1997.2.1.11.
3
Regulatory aspects of invasive glucose measurements.侵入性血糖测量的监管方面。
Diabetes Technol Ther. 2002;4(6):775-7. doi: 10.1089/152091502321118784.
4
Medical devices; exemptions from premarket notification; class II devices--FDA, Final rule.医疗器械;免于上市前通知;II类器械——美国食品药品监督管理局,最终规则
Fed Regist. 1998 Nov 3;63(212):59222-31.
5
Characteristics of Clinical Studies Conducted Over the Total Product Life Cycle of High-Risk Therapeutic Medical Devices Receiving FDA Premarket Approval in 2010 and 2011.2010 年和 2011 年 FDA 上市前批准的高风险治疗性医疗器械全产品生命周期临床试验特点。
JAMA. 2015 Aug 11;314(6):604-12. doi: 10.1001/jama.2015.8761.
6
Medical devices; exemptions from premarket notification and reserved devices; class I--FDA. Notice.医疗器械;免于上市前通知和保留器械;I类——美国食品药品监督管理局。通知。
Fed Regist. 1998 Feb 2;63(21):5387-93.
7
Medical devices; exemption from premarket notification and reserved devices; class I. Food and Drug Administration, HHS. Final rule.医疗器械;免于上市前通知和保留器械;I类。美国卫生与公众服务部食品药品监督管理局。最终规则。
Fed Regist. 2000 Jan 14;65(10):2296-323.
8
What physicians should know about the regulation of Obstetric and Gynecologic Medical Devices.医生应该了解的关于妇产科医疗器械监管的知识。
J Reprod Med. 1983 Jan;28(1):3-11.
9
Medical Devices; Exemption From Premarket Notification; Class II Devices; Electric Positioning Chair. Final order.医疗器械;免于上市前通知;II类器械;电动定位椅。最终命令。
Fed Regist. 2015 Nov 20;80(224):72589-91.
10
Medical device recalls and the FDA approval process.医疗器械召回与美国食品药品监督管理局(FDA)的审批流程。
Arch Intern Med. 2011 Jun 13;171(11):1006-11. doi: 10.1001/archinternmed.2011.30. Epub 2011 Feb 14.

引用本文的文献

1
Advancements in materiovigilance: A comprehensive overview.药物警戒的进展:全面概述。
Perspect Clin Res. 2025 Jul-Sep;16(3):111-117. doi: 10.4103/picr.picr_66_24. Epub 2025 May 28.
2
Importance to understand medical device regulations for accelerating clinical translation.理解医疗器械法规对于加速临床转化很重要。
J Orthop Translat. 2025 Mar 20;51:290-297. doi: 10.1016/j.jot.2025.02.002. eCollection 2025 Mar.
3
A Comprehensive Analysis of Class I Medical Device Recalls: Unveiling Patterns, Causes and Global Impacts.
I类医疗器械召回的综合分析:揭示模式、原因及全球影响
Cureus. 2024 Aug 22;16(8):e67542. doi: 10.7759/cureus.67542. eCollection 2024 Aug.
4
Robotic Pills as Innovative Personalized Medicine Tools: A Mini Review.机器人药丸作为创新的个性化医疗工具:小型综述。
Recent Adv Drug Deliv Formul. 2024;18(1):2-11. doi: 10.2174/0126673878265457231205114925.
5
Progress in Wound-Healing Products Based on Natural Compounds, Stem Cells, and MicroRNA-Based Biopolymers in the European, USA, and Asian Markets: Opportunities, Barriers, and Regulatory Issues.欧洲、美国和亚洲市场基于天然化合物、干细胞和基于微小RNA的生物聚合物的伤口愈合产品进展:机遇、障碍与监管问题
Polymers (Basel). 2024 May 3;16(9):1280. doi: 10.3390/polym16091280.
6
Safety reporting of Essure medical device: a qualitative and quantitative assessment on the FDA manufacturer and user facility device experience database in 2018.依溯节育器医疗器械的安全性报告:对2018年美国食品药品监督管理局制造商和用户设施器械经验数据库的定性与定量评估
Front Reprod Health. 2023 Jul 13;5:1172927. doi: 10.3389/frph.2023.1172927. eCollection 2023.
7
Characteristics of pivotal clinical trials of FDA-approved endovascular devices between 2000 and 2018: An interrupted time series analysis.2000年至2018年间美国食品药品监督管理局批准的血管内装置关键临床试验的特征:一项中断时间序列分析。
J Clin Transl Sci. 2023 Feb 3;7(1):e67. doi: 10.1017/cts.2023.10. eCollection 2023.
8
Systems and processes for regulation of investigational medical devices in Uganda.乌干达用于监管试验性医疗器械的系统和流程。
Front Med Technol. 2023 Jan 23;4:1054120. doi: 10.3389/fmedt.2022.1054120. eCollection 2022.
9
Mapping the genealogy of medical device predicates in the United States.绘制美国医疗器械谓词的谱系图。
PLoS One. 2021 Oct 7;16(10):e0258153. doi: 10.1371/journal.pone.0258153. eCollection 2021.
10
Changing Health-Related Behaviors 6: Analysis, Interpretation, and Application of Big Data.改变健康相关行为 6:大数据的分析、解释和应用。
Methods Mol Biol. 2021;2249:631-644. doi: 10.1007/978-1-0716-1138-8_34.